Skip to content
healthcare.dev

Ondansetron

NDC 68462-157, Ondansetron, tablet, orally disintegrating, from Glenmark Pharmaceuticals Inc., USA.

Product NDC
68462-157
Status
Listed
Labeler
Glenmark Pharmaceuticals Inc., USA
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078152
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68462-157 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ONDANSETRON4 mg/1

Pharmacologic classes

Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]

Package NDCNDC-11Package
68462-157-136846201571330 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (68462-157-13)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/eee5217a-eba8-463a-812d-bf3c66f0934f
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=68462-157
  • NADAC price for package 68462015713

    GET /v1/drugs/nadac/68462015713

Use it

Look up 68462-157 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68462-157 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68462-157. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.